|
KIAA0146 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.66359999997923E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.586400E-04 |
| Normal-vs-Stage2 |
5.567100E-04 |
| Normal-vs-Stage3 |
2.17170000005318E-06 |
| Normal-vs-Stage4 |
7.92660000000778E-05 |
| Stage1-vs-Stage2 |
1.574380E-01 |
| Stage1-vs-Stage3 |
6.524000E-02 |
| Stage1-vs-Stage4 |
1.735790E-01 |
| Stage2-vs-Stage3 |
9.513600E-01 |
| Stage2-vs-Stage4 |
9.208600E-01 |
| Stage3-vs-Stage4 |
9.557800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.91559999995761E-06 |
| Normal-vs-AfricanAmerican |
1.078380E-01 |
| Normal-vs-Asian |
5.464400E-02 |
| Caucasian-vs-AfricanAmerican |
2.131000E-01 |
| Caucasian-vs-Asian |
7.950400E-02 |
| AfricanAmerican-vs-Asian |
9.580600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.311700000037E-06 |
| Normal-vs-Female |
1.97570000000091E-05 |
| Male-vs-Female |
2.098000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.975000E-04 |
| Normal-vs-Age(41-60Yrs) |
9.60909999999648E-05 |
| Normal-vs-Age(61-80Yrs) |
8.06149999976746E-07 |
| Normal-vs-Age(81-100Yrs) |
5.322800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.147000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.289600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.707800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.029830E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.369200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.343200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.883120E-03 |
| Classical-VS-Follicular |
1.015910E-03 |
| Classical-VS-Other |
4.786300E-02 |
| Classical-VS-Normal |
6.481500E-03 |
| Tall-VS-Follicular |
6.105400E-01 |
| Tall-VS-Other |
6.600400E-01 |
| Tall-VS-Normal |
4.60830000048595E-07 |
| Follicular-VS-Other |
5.988000E-01 |
| Follicular-VS-Normal |
6.99550000038407E-07 |
| Other-VS-Normal |
7.804900E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.68839999997927E-06 |
| Normal-vs-N1 |
9.80219999999754E-05 |
| N0-vs-N1 |
6.619000E-01 |
|
|
